Can LAB exopolysaccharides act as therapeutic biomolecules?
Among 10 strains, L. delbrueckii EPS5 had top yield and strong cytotoxicity (IC50 ~7.9–10.7 mg/ml) plus fibroblast-supportive effects.
Source
Exploring the Therapeutic Potentials of Exopolysaccharides Derived From Lactic Acid Bacteria and Bifidobacteria: Antioxidant, Antitumor, and Periodontal Regeneration
What they did
Isolated EPS from LAB/Bb supernatants and tested concentration-dependent antioxidant, MTT antitumor, and human periodontal ligament fibroblast assays.
What they found
EPS yields 174.9–295.4 mg/l; DPPH scavenging 33.3–77% at 20 mg/ml; EPS5 most cytotoxic to MCF7/CaCo2/HepG2 and increased hPDLFC viability.
The limits
What it doesn't show
In vitro only—does not prove clinical cancer therapy or safe replacement of chemotherapeutics.
Key terms
- EPS
- Exopolysaccharides secreted by bacteria.
- LAB
- Lactic acid bacteria, often GRAS food microbes.
- DPPH assay
- In vitro radical-scavenging antioxidant test.
- IC50
- Concentration giving 50% cytotoxicity/inhibition.
- hPDLFCs
- Human periodontal ligament fibroblast cells.
- EPS 5
- EPS from L. delbrueckii ssp. bulgaricus DSM 20081T.
Flashcards
Research intelligence for this paper
See its role on concept claims, tensions it is part of, placement history, and related discoveries.
Quiz yourself
Number of strains:
Common questions
How many strains?
10 (9 LAB, 1 Bb).
Highest EPS yield?
EPS5 ~295.4 mg/l.
EPS5 IC50s?
7.91 / 10.69 / 9.12 mg/ml (MCF7/CaCo2/HepG2).
Periodontal angle?
EPS5 increased hPDLFC viability.
More on microbiology